Stay updated with breaking news from Ah004. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BEIJING, Dec. 9, 2021 /PRNewswire/ Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I clinical trial of YH004 (anti-4-1BB monoclonal ....